تحميل...
Neoadjuvant endocrine therapy in breast cancer patients
HIGHLIGHTS: The overall response rate to neoadjuvant endocrine therapy (NET) was 54.55%. The eight patients proposed to tumour's downstage, after 9.71 months of NET, preserved their breast. In the group which achieved response, 10.28 months was the mean time to accomplish it. Even patients who...
محفوظ في:
| الحاوية / القاعدة: | Porto Biomed J |
|---|---|
| المؤلفون الرئيسيون: | , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Faculty of Medicine of the University of Porto
2017
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806912/ https://ncbi.nlm.nih.gov/pubmed/32258615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbj.2017.03.007 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|